Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Peritoneal Primary Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT04861558
What this trial is testing

Efficacy of Hyperthermic Intraperitoneal Chemotherapy

Who this might be right for
Colorectal CancerPeritoneal Metastases
Uppsala University 213
Testing effectiveness (Phase 2)Study completedNCT00022347
What this trial is testing

TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00005049
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer

Who this might be right for
Colorectal CancerGastric CancerGastrointestinal Carcinoid Tumor+4 more
NYU Langone Health 45
Early research (Phase 1)Study completedNCT00003358
What this trial is testing

Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Memorial Sloan Kettering Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT05198804
What this trial is testing

Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer

Who this might be right for
Ovarian CancerPlatinum-resistant Ovarian CancerPrimary Peritoneal Carcinoma+1 more
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc 117
Not applicableStudy completedNCT01982500
What this trial is testing

Observation of Bevacizumab Plus Front-line Chemotherapy in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hellenic Oncology Research Group 200
Large-scale testing (Phase 3)Looking for participantsNCT06994195
What this trial is testing

A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01)

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 450
Early research (Phase 1)Study completedNCT02303912
What this trial is testing

Safety and Efficacy Study of Nuc-1031 and Carboplatin Combination to Treat Recurrent Ovarian Cancer

Who this might be right for
Recurrent Ovarian Cancer
Imperial College Healthcare NHS Trust 25
Testing effectiveness (Phase 2)Ended earlyNCT00903630
What this trial is testing

Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Masonic Cancer Center, University of Minnesota 15
Testing effectiveness (Phase 2)Ended earlyNCT02900560
What this trial is testing

Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Translational Research in Oncology 34
Large-scale testing (Phase 3)Looking for participantsNCT05303714
What this trial is testing

PIPAC in Multimodal Therapy for Patients with Oligometastatic Peritoneal Gastric Cancer

Who this might be right for
Oligometastatic Gastric Adenocarcinoma
Azienda Ospedaliera Universitaria Integrata Verona 98
Large-scale testing (Phase 3)Study completedNCT02477644
What this trial is testing

Platine, Avastin and OLAparib in 1st Line

Who this might be right for
Ovarian Cancer
Arcagy Research 806
Testing effectiveness (Phase 2)Study completedNCT00059787
What this trial is testing

Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma

Who this might be right for
Brenner TumorFallopian Tube CancerOvarian Clear Cell Cystadenocarcinoma+6 more
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)UnknownNCT06487715
What this trial is testing

Safety and Efficacy of Systemic Chemotherapy Plus PD-1 Inhibitor in Combination With Bevacizumab in Gastric Cancer With Peritoneal Metastasis

Who this might be right for
Gastric Cancer Peritoneal Metastases
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 42
Testing effectiveness (Phase 2)Looking for participantsNCT05200260
What this trial is testing

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Shanghai Gynecologic Oncology Group 220
Not applicableStudy completedNCT02295982
What this trial is testing

Laparoscopic Versus Hand Assisted Laparoscopic Trans-peritoneal Laparoscopic Nephrectomy as One Day Surgery (i.e.: Are There Differences in Postoperative Outcome / Convalescence)

Who this might be right for
Renal Cancer
Zealand University Hospital 30
Testing effectiveness (Phase 2)UnknownNCT01570582
What this trial is testing

A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cancer
Korean Gynecologic Oncology Group 314
Not applicableUnknownNCT04122885
What this trial is testing

Study of Plasma Tumor-promoting Factors and Immune Function After Laparotomy, Cytoreductive Surgery and HIPEC vs. PIPAC in Patients With Peritoneal Metastasis

Who this might be right for
Peritoneal CancerChemotherapy-Induced Change
University Hospital Tuebingen 60
Testing effectiveness (Phase 2)Study completedNCT00193297
What this trial is testing

Topotecan Plus Paclitaxel and Carboplatin in the Initial Treatment of Advanced Ovarian and Primary Peritoneal Carcinoma

Who this might be right for
Ovary Cancer
SCRI Development Innovations, LLC 50
Testing effectiveness (Phase 2)WithdrawnNCT06393751
What this trial is testing

Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer

Who this might be right for
Platinum-Refractory Fallopian Tube CarcinomaPlatinum-Refractory Ovarian CarcinomaPlatinum-Refractory Primary Peritoneal Carcinoma+20 more
National Cancer Institute (NCI)
Next Page